Presentation is loading. Please wait.

Presentation is loading. Please wait.

Delirium in cancer palliative care

Similar presentations


Presentation on theme: "Delirium in cancer palliative care"— Presentation transcript:

1 Delirium in cancer palliative care
Augusto Caraceni Chief of Palliative Care, Pain Therapy Rehabilitation Fondazione IRCCS National Cancer Institute Milan, Italy

2 In the beginning 29 April 1965 to Dr RobertTwycross
“.... I hope we will continue to reduce this figure when we have St Christopher’s and when we learn more about the relief of mental suf fering and confusion, which as you see remain the big problem” 16 August 1976 To Prof. Exton Smith “…the confusion which many patients experience …we agreed that, all too often, this is and remains somewhat of a mistery” David Clark: “Cicely Saunders Founder of the Hospice movement selected letters ” Oxford University Press 2002

3 A problem of definition ?
Ippocrates frenitis Celsus (25 b.C – 50 a.C.) and then Areteus from Cappadocia delirium Greiner 1817 Verdunkelung des Bewusstseins (Obnubilation of consciousness) Chaslin 1895 La confusion mental primitive Lipowski 1990

4 Lipowski and the modern concept
“Delirium is a transient organic mental syndrome of acute onset, characterized by global impairment of cognitive functions, a reduced level of consciousness, attentional abnormalities, increased or decreased psychomotor activity, and a disordered sleep-wake cycle” Lipowski Z.J. Delirium: acute confusional states OUP 1990

5 Delirium DSM IV diagnostic criteria
Disturbance of consciousness (i.e reduced clarity of awareness of the environment) with reduced ability to focus, sustain and shift attention Change in cognition or the development of perceptual disturbances Develops in hours to days and fluctuates Is caused by the direct physiological consequence of a general medical condition Diagnostic and statistical manual of mental disorders (DSM) IV – TR APA 2000

6 Consciousness (awareness of self and environment) as a filter controlling the quality and quantity of stimuli reaching consciousness taste smell touch sound sight Environment pain memories Body Unconscious breathing hopes body position sense fears hunger From Averil Stedeford in: Bates TD (Ed) Contemporary Palliation of Difficult Symptoms Balliere’s and Tindall, London 1987, Br J Hosp Med 1978; 20 (6) : ,

7 Consciousness and attention
We are always conscious of something. The ability of the brain to have different levels of awareness of stimuli and experience is dependent on attention which can be viewed as the gateway to awareness A fundamental aspect of this integrative function is taken by attention that can be viewed as the gateway to awareness by selectin stimuli, experiernces and actions that can be preset to consciousness at a given time - Attention and arousal neurophysiological mechanisms are linked and dependent

8 Pathogenesis, the ascending reticular activating system Moruzzi and Magoun 1949
Reproduced from Magoun 1952

9 Conscious states = wakefulness and sleep
Cholinergic n. (opioids) Noradrenergic n. (Clonidine) Histaminergic n. (prometazine) Dopaminergic n. (haloperidol) Serotonergic n (ssri) Gabaergic (Benzodiazepine propofol) Cortex Thalamus In more modern terms we know that a numeber of neurotrasmitters can be found in the same structures and have a role in regulating sleep and wakefulness under normal condition Please note that these neuronal pathways are at the same time the target of toxic effects due to poisoning or disease and the target of pharmacological interventions aimed at different therapeutic outcomes

10 Pathological states of consciousness
Clinical condition Wakefulness Awareness Coma Absent Vegetative state Present Delirium Abnormal From the recognition of anatomical, neurophysiologica and neurochemical mechanisms derives the fact that the conditions fund in human diseases has to find an explanation By concentrating artificially on only two major clinical aspects we can see that vigilance (the activated state of wakefulness) and awareness can be differentially affected and manifest as specific clinical conditions

11 Epidemiology of delirium comparing oncology with palliative care with elderly populations
Authors Prevalence Incidence ≥ 70 Francis (1990) 16.0 06.0 ≥ 65 Levfkoff (1992) 10.5 31.3 Inouye (1993) 25.0 Inouye (1996) 18.0 Oncology Ljubisavjevic (2003) Gaudreau (2005) 16.5 Hospice Minagawa (1999) 28.0 PC Unit Lawlor(2000) 42.0 45.0 Homecare Caraceni(2000) - Dying patient Massie et al.(1983) 85 From Caraceni & Simonetti The Lancet Oncology In Press

12 Differential diagnosis
Clinical Aspect DELIRIUM DEMENZA ACUTE PSYCHOSIS onset acute insidious 24 hour course fluctuating stable Level of consciousness reduced spared Attention abnormal Initially spared Can be abnormal Cognitive functions Can be compromised Hallucinations Often visual Usually absent Usually auditory Delusions Poorly organized impersistent Often absent Complex and persistent Psychomotor activity Increased, reduced, mixed, fluctuating Normal Variable with bizzarre behaviour Involuntary movements asterixis, myoclonus or tremors Absent EEG abnormal* normal

13 Prodromal symptoms and signs
Insomnia Vivid dreams , nightmeres Agitation Irritability Distractability Ipersensitivity to sounds, lights Anxiety/depression Concentration difficulties Difficulties in marshalling own thought Unusual behaviours Behaviour changes Hypo hyperactivity

14 Clinical assessment Assessement of the level of consciousness
Assessment of cognitive functions Hallucinations Delusions Incoherent thought Written and spoken language Neurologic signs

15 Should specific delirium scales be used routinely in palliative care?
Diagnostic instruments CAM (Confusion Assessment Method) Inouye et al Ann Int Medicine 1999, Ryan et al Pall Med 2009) Delirium symptom interview (Albert et al , J Geriatr Psych Neurol 1992) Nursing delirium screening scale (Gaudreau et al J Pain Sympt Manage 2005) Descriptive, assessing severity, specific DRS , MDAS Non specific of delirium but assessing cognitive functions in general MMSE

16 Screening for delirium
In the MMSE 4 items over 20 are sufficient to screen for delirium Orientation to year Orientation to date backward spelling copy design NUDESC Disorientation Behaviour Communication Illusion Hallucination Psychomotor And indeed this reasearch conducted with very careful statistical analysis in a sample of more than 500 patients shows that the items of the MMSE examination that is so popular for assessing cognitive functions also in PC patients that are needed to screen for delirium are indeed only 4 pointing again at temporal orientatuìion and at at other performces which might be well influenced by change in attention and arousal The ability to develop instruments finally accuarate to identify this and other affections of cosnciousness needs to be rooted onsome theory and than validated into practice One recent example could regad the Nursing Delrium SCreening Scale that has been recently published Fayers PM et al J Pain Sympt Manage 2005; 30: 41-50 Gaudreau et al. The nursing delirium screening scale J Pain Sympt Manage 2005; 29:

17 Delirium scales DRS and DRS-revised-98 (Trzepacz et al 1988, 2001)
Memorial delirium assessment scale (Breitbart et al 1997) Confusional state evaluation (Robertson et al 1997) Cognitive test for delirium (ICU) (Hart et al 1996) Delirium Index (Mc Cusker et al 1998) Delirium writing test (Aakerlund and Rosenberg 1994) Communication capacity scale and Agitation distress scale (Morita et al 2001) (Morita JPSM, 2003; 26: ) Delirium assessment scale (O’Keefe et al 1994) Intensive care delirium screening checklist (Dubois et al 2001) Delirium severity scale (Bettin et al 1998) From: Caraceni A and Grassi L, Delirium acute confusional states in palliative medicine OUP 2003

18 Perceptual disturbances 0-3 Hallucinations type 0-3 Delusions 0-3
Temporal onset 0-3 Perceptual disturbances 0-3 Hallucinations type 0-3 Delusions 0-3 Psychomotor behavior 0-3 Cognitive status 0-4 Physical disorder 0-2 Sleep wake cycle dist. 0-4 Lability of mood 0-3 Variability of symptoms max 32 DELIRIUM RATING SCALE Trzepacz P Psych Res 1987 J Neuropsychiatry Clin Neurosci :

19 Level of consciousness 0-3 Disorientation 0-3 Short term memory 0-3
Digit span 0-3 Attention 0-3 Thought 0-3 Perceptual disturbances 0-3 Delusions 0-3 Psychomotor activity 0-3 Sleep-wake cycle dist Max 30 MEMORIAL DELIRIUM ASSESSMENT SCALE Breitbart et al JPSM, 1997

20 Writing abnormalities
Macleod & Whitehead Palliative Medicine 1997; 11: 127 Tremors Perseveration

21 Writing abormalities

22 Causes of delirium in cancer patients
Structural Brain metastases Meningeal metastases Non cancer related (vascular, infectious) Non structural Metabolic encephalopathy Systemic Infectio Hematologic disorders (DIC) Nutritional Toxicity of chemotherapy or radiation therapy Toxicity of other drugs Paraneoplastic neurologic syndromes Alcohol and drug withdrawal

23 Seizures It is possible that seizures present with clinical features which overlap with delirium

24 Delirium EEG slowing Non convulsive status epilepticus

25 Structural causes of delirium in cancer patients
1 2 3 4 5

26 Screening of causes Toxic drug screening and history
Sepsis Temperature, coltures, leucocyte, PCR Glucose oxydative blood gases metabolism Electrolytes Na, K, Mg, Ca, Cl Renal function Uremia, Creatinine cl. Liver function Ammonio Cofactor deficiency B1, B12 Tyroid (endocrine) T3, T4, TSH, others ? Epilepsy EEG Paraneoplastic syndrome Specific autoantiboides

27 Pathogenesis-etiology
Multiple factors are almost always identified Drug toxicity and concurrent or predisponsing factors (the soil concept)

28 Risk factors in cancer patients at multivariate analysis
Age Previous cognitive failure Severity of associated illness Functional impairment Renal function Metabolic abnormalities Low albumin Bone metastases Liver metastases History of delirium Metastasis to CNS Opiods Benzodiazepines Fever infection Caraceni & Simonetti Lancet Oncology IN PRESS

29 A multifactor model Risk factors Precipitating factors
Vision impairment Severity of illness Cognitive impairment BUN/creatinine ratio Precipitating factors Physical restrains Malnutrition > 3 medications Bladder catheter Any iatrogenic event Inouye and Charpentier JAMA 1996

30 DELIRIUM Toxic , Metabolic , Brain lesion
INCIDENT FACTORS: Toxic , Metabolic , Brain lesion PREDISPOSING FACTORS: Cognitive Failure, Age , Dementia , Brain lesion DELIRIUM

31 Multifactor model with baseline vulnerability and precipitating factors
High vulnerability Noxious insult Less noxious insult Low vulnerability Inouye and Chapentier JAMA 1996

32 Precipitating factors in 40 reversible episodes
Factor Prob. Poss. Total Opioids Psy. Drugs Dehydration Nonresp. Infection Alcohol withdrawal 2 2 4 Intracranial cause 3 0 3 Hypoxia Metabolic Hematologic Totals Lawlor et al Arch Int Med 2000

33 Precipitating factors and reversibility in PC
Type of factor Reversed Non rev. Hazard r. (95 C.I.) Psychoactive d. 38 (95%) 15 (48%) (1.5-29) Dehydration 26 (65%) 8 (26%) (.7-3.2) Hypoxia 11 (28%) 22 (71%) (.15-.7) Miscellaneous 7 (18%) 7 (23%) Nonresp. Infection 10 (25%) 8 (26%) Metabolic 10 (25%) 18 (58%) Hematologic 5 (13%) 7 (23%) Lawlor P. et al 2000 Arch Int Med

34 Delirium reversibility in hospice
Total 121 Cases reversible irreversible 33 (27%) 88 (73%) survival 39+/ /- 10 organ failure attention vigilance Leonard et al Pall Med 2008; 22 :

35 Delirium and prognosis
Delirium is independently associated with reduced survival at 12 month (McCusker 2002) In advanced cancer patients it is independently associated with worse prognosis to 30 days (Caraceni et al Cancer 2000) PaP score (Maltoni et al JPSM 1999) Il 50% of delirium episodes in PC are reversible (Lawlor Arch Int Med 2001)

36 Impact of delrium on survival curves after the beginning of palliative care programmes A, B and C identify three different prognostic groups according to the PaP score 30 60 90 120 150 180 DAYS 0,2 0,4 0,6 0,8 1 C B A SURVIVAL % - - = delirious ___ = not delirious Caraceni et al Cancer 1999


Download ppt "Delirium in cancer palliative care"

Similar presentations


Ads by Google